Biomarkers for Predicting the Occurrence and Progression of Atrial Fibrillation: Soluble Suppression of Tumorigenicity 2 Protein and Tissue Inhibitor of Matrix Metalloproteinase-1

<div>A receiver operator characteristic curve analysis for the progression of atrial fibrillation. (a) Sinus rhythm and atrial fibrillation. (b) Sinus rhythm and paroxysmal atrial fibrillation. (c) Sinus rhythm and persistent atrial fibrillation.</div>

International Journal of Clinical Practice

fig3

Figure 3

Figure 3: Biomarkers for Predicting the Occurrence and Progression of Atrial Fibrillation: Soluble Suppression of Tumorigenicity 2 Protein and Tissue Inhibitor of Matrix Metalloproteinase-1 

Figure 3 | Biomarkers for Predicting the Occurrence and Progression of Atrial Fibrillation: Soluble Suppression of Tumorigenicity 2 Protein and Tissue Inhibitor of Matrix Metalloproteinase-1 